{"id":1010778,"date":"2026-10-15T16:43:31","date_gmt":"2026-10-15T20:43:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\/"},"modified":"2026-10-15T16:43:31","modified_gmt":"2026-10-15T20:43:31","slug":"frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\/","title":{"rendered":"Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering"},"content":{"rendered":"

<\/p>\n

Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering<\/b><\/p>\n

PALO ALTO, Calif.–(BUSINESS WIRE<\/a>)–
\nFrazier Life Sciences Acquisition Corp. II (the \u201cCompany\u201d), a special purpose acquisition company, announced today the closing of its initial public offering of 7,500,000 Class A ordinary shares at a price of $10.00 per share. The Class A ordinary shares are listed on The Nasdaq Capital Market and began trading under the ticker symbol \u201cFLSC\u201d as of October 14, 2026.<\/p>\n

\nThe Company was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company is sponsored by Frazier Life Sciences Holdings II, LLC, an affiliate of Frazier Life Sciences Management, L.P., and is led by Chief Executive Officer Albert Cha, MD, PhD, Chairman of the Board of Directors Ben Palleiko, and Chief Business Officer Kevin Li, M.D. While the Company may pursue an acquisition opportunity in any business, industry, sector or geographical location, it intends to capitalize on the experience and ability of its management team to identify promising opportunities in the biotechnology sector, with the goal of financing a company that can develop important new therapies for patients while creating value for shareholders.<\/p>\n

\nJefferies acted as the sole book-running manager for the offering.<\/p>\n

\nThe offering was made only by means of a prospectus. Copies of the prospectus may be obtained from Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, or by telephone at 877-821-7388 or by email at Prospectus_Department@Jefferies.com<\/a>, or by accessing the Securities and Exchange Commission\u2019s (the \u201cSEC\u201d) website, www.sec.gov<\/a>.<\/p>\n

\nA registration statement relating to these securities was declared effective by the SEC on October 13, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.<\/p>\n

CAUTIONARY NOTE CONCERNING FORWARD-LOOKING STATEMENTS<\/b><\/p>\n

\nThis press release contains statements that constitute \u201cforward-looking statements,\u201d including with respect to the Company\u2019s search for an initial business combination. No assurance can be given that the proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company\u2019s registration statement for the initial public offering filed with the SEC. Copies are available on the SEC\u2019s website, www.sec.gov<\/a>. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20261015603789\/en\/<\/a><\/span><\/p>\n

\nKevin Li, M.D.
\n
Chief Business Officer
\n
1001 Page Mill Road,
\n
Building 4, Suite 200B
\n
Palo Alto, CA 93404
\n
Tel.: (650) 325-5156
\n
Email: KL@frazierls.com<\/a><\/p>\n

KEYWORDS:<\/b> California United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology Finance Health Professional Services Pharmaceutical<\/p>\n

MEDIA:<\/b><\/p>\n\n","protected":false},"excerpt":{"rendered":"

Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering PALO ALTO, Calif.–(BUSINESS WIRE)– Frazier Life Sciences Acquisition Corp. II (the \u201cCompany\u201d), a special purpose acquisition company, announced today the closing of its initial public offering of 7,500,000 Class A ordinary shares at a price of $10.00 per share. The Class A ordinary shares are listed on The Nasdaq Capital Market and began trading under the ticker symbol \u201cFLSC\u201d as of October 14, 2026. The Company was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company is sponsored by Frazier Life Sciences Holdings II, LLC, an affiliate … <\/p>\n

Continue reading “Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1010778","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nFrazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering PALO ALTO, Calif.–(BUSINESS WIRE)– Frazier Life Sciences Acquisition Corp. II (the \u201cCompany\u201d), a special purpose acquisition company, announced today the closing of its initial public offering of 7,500,000 Class A ordinary shares at a price of $10.00 per share. The Class A ordinary shares are listed on The Nasdaq Capital Market and began trading under the ticker symbol \u201cFLSC\u201d as of October 14, 2026. The Company was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company is sponsored by Frazier Life Sciences Holdings II, LLC, an affiliate … Continue reading "Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-15T20:43:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20261015603789r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering\",\"datePublished\":\"2026-10-15T20:43:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\\\/\"},\"wordCount\":534,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20261015603789r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\\\/\",\"name\":\"Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20261015603789r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2026-10-15T20:43:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20261015603789r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20261015603789r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\/","og_locale":"en_US","og_type":"article","og_title":"Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering - Market Newsdesk","og_description":"Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering PALO ALTO, Calif.–(BUSINESS WIRE)– Frazier Life Sciences Acquisition Corp. II (the \u201cCompany\u201d), a special purpose acquisition company, announced today the closing of its initial public offering of 7,500,000 Class A ordinary shares at a price of $10.00 per share. The Class A ordinary shares are listed on The Nasdaq Capital Market and began trading under the ticker symbol \u201cFLSC\u201d as of October 14, 2026. The Company was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company is sponsored by Frazier Life Sciences Holdings II, LLC, an affiliate … Continue reading \"Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-15T20:43:31+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20261015603789r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering","datePublished":"2026-10-15T20:43:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\/"},"wordCount":534,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20261015603789r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\/","name":"Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20261015603789r1&sid=flmnd&distro=nx&lang=en","datePublished":"2026-10-15T20:43:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20261015603789r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20261015603789r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/frazier-life-sciences-acquisition-corp-ii-announces-completion-of-75000000-initial-public-offering\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1010778","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1010778"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1010778\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1010778"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1010778"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1010778"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}